The Patent Finder

Myriel Pharmaceuticals, LLC

Also on record
Records under this name other than the patents Myriel Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Showing 1 to 2 of 2 · Back to Myriel Pharmaceuticals, LLC

PatentTitleStatus Expires Confidence
US 10,076,525Sex Steroid Precursors Alone or in Combination with Selective Estrogen Receptor Modulators for the Prevention and Treatment of Dyspareunia in Postmenopausal Women
Term ended
Term ended Oct 20, 2025 · High confidence
Term endedTerm ended Oct 20, 2025High confidence
US 10,478,443Sex Steroid Precursors Alone or in Combination with Selective Estrogen Receptor Modulators for the Prevention and Treatment of Sexual Dysfunction in Postmenopausal Women
Term ended
Term ended Oct 20, 2025 · High confidence
Term endedTerm ended Oct 20, 2025High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited